ILDong: Ildong's new anticancer drug Venadaparib draws attention in clinical trial

Ildong Pharmceutical's independently developed targeted anticancer drug, Venadaparib (IDX-1197 in development name), has been used to treat patients in clinical fields, drawing the industry's attention.The Ministry of Food and Drug Safety approved the drug's use to treat two patients last Friday.It